Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Measles vaccine strain from the skin rash of a DiGeorge patient receiving tumor necrosis factor inhibitor.

Literature DB >> 24346604

Measles vaccine strain from the skin rash of a DiGeorge patient receiving tumor necrosis factor inhibitor.

Pui-Ying Iroh Tam¹, Benjamin R Hanisch, Kate Klammer, Aaron S DeVries.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Measles Vaccine

Year: 2014 PMID： 24346604 PMCID： PMC4385583 DOI： 10.1097/INF.0000000000000073

Source DB: PubMed Journal: Pediatr Infect Dis J ISSN： 0891-3668 Impact factor: 2.129

Keyword Cloud
References

× No keyword cloud information.

10 in total

1. Propagation in tissue cultures of cytopathogenic agents from patients with measles.

Authors: J F ENDERS; T C PEEBLES
Journal: Proc Soc Exp Biol Med Date: 1954-06

2. Genetic characterization of measles vaccine strains.

Authors: Bettina Bankamp; Makoto Takeda; Yan Zhang; Wenbo Xu; Paul A Rota
Journal: J Infect Dis Date: 2011-07 Impact factor: 5.226

3. Improving molecular tools for global surveillance of measles virus.

Authors: Bettina Bankamp; Lauren A Byrd-Leotis; Elena N Lopareva; Gibson K S Woo; Chunyu Liu; Youngmee Jee; Hinda Ahmed; Wilina W Lim; Nalini Ramamurty; Mick N Mulders; David Featherstone; William J Bellini; Paul A Rota
Journal: J Clin Virol Date: 2013-06-24 Impact factor: 3.168

4. Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens.

Authors: Kimberly B Hummel; Luis Lowe; William J Bellini; Paul A Rota
Journal: J Virol Methods Date: 2005-11-07 Impact factor: 2.014

Measles vaccine strain from the skin rash of a DiGeorge patient receiving tumor necrosis factor inhibitor.

1. Propagation in tissue cultures of cytopathogenic agents from patients with measles.

2. Genetic characterization of measles vaccine strains.

3. Improving molecular tools for global surveillance of measles virus.

4. Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens.

5. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993.

6. Disseminated measles infection after vaccination in a child with a congenital immunodeficiency.

7. Detection and comparison of viral antigens in measles and rubella rashes.

8. Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis.

9. Development of a dual target-PCR for detection and characterization of measles virus in clinical specimens.

10. Detection of measles virus RNA in urine specimens from vaccine recipients.